WebPrior to joining Caraway therapeutics, Mr. Williams was the President and CEO of Tokai Pharmaceuticals, an oncology company with a small molecule in Phase 2 for prostate cancer. ... Financial Officer at Scholar Rock where sheplayed a key role in Scholar Rock’s initial public offering, subsequent financing, and led the buildout of the ... WebJul 17, 2024 · Information on valuation, funding, cap tables, investors, and executives for Caraway Therapeutics. Use the PitchBook Platform to explore the full profile. Request a …
Caraway Therapeutics to Present at 22nd Annual Needham …
WebFinance/Funding. Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases (Nov-2024) ... Caraway Therapeutics Recommended Market Profiles (6) Telemedicine. 10,000 or More employees. 19 companies. Big Data Universe List of Lists. 10,000 or More employees. WebJun 9, 2024 · Caraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined neurodegenerative and rare diseases. The company is a leader in the cutting ... brewery in north bay
Caraway Therapeutics to Present at the 33rd Annual …
WebMar 22, 2024 · Caraway Therapeutics today announced that the Company will be participating in the Stifel CNS Days event on March 29, 2024. Caraway's Chief Executive Officer, Martin D. Williams, will present ... WebMar 22, 2024 · By: Caraway Therapeutics via Business Wire. March 22, 2024 at 08:00 AM EDT. Caraway Therapeutics today announced that the Company will be participating in the Stifel CNS Days event on March 29, 2024. Caraway’s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company’s TRPML1 CNS program from … WebJul 6, 2024 · CAMBRIDGE, Mass., July 06, 2024 -- ( BUSINESS WIRE )-- Caraway Therapeutics today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July ... country smokers traveler pellet grill reviews